Zacks: National Research Co. (NRCIA) Given Average Recommendation of “Hold” by Analysts

Shares of National Research Co. (NASDAQ:NRCIA) have been given an average broker rating score of 3.00 (Hold) from the one brokers that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a hold rating.

Zacks has also given National Research an industry rank of 96 out of 265 based on the ratings given to its competitors.

NRCIA has been the topic of several recent analyst reports. Zacks Investment Research downgraded National Research from a “hold” rating to a “strong sell” rating in a research note on Friday, November 10th. BidaskClub upgraded National Research from a “hold” rating to a “buy” rating in a report on Wednesday, December 27th.

Shares of National Research (NRCIA) traded down $0.60 on Wednesday, reaching $36.05. The company had a trading volume of 19,867 shares, compared to its average volume of 23,514. The company has a market cap of $893.59, a P/E ratio of 72.10 and a beta of 1.63. National Research has a 52 week low of $16.50 and a 52 week high of $41.99.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 12th. Shareholders of record on Friday, December 29th will be issued a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 1.11%. The ex-dividend date is Thursday, December 28th. National Research’s dividend payout ratio is presently 80.00%.

In other National Research news, major shareholder K/I/E/Trust Under Agreement 3/ sold 9,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $36.50, for a total transaction of $328,500.00. Following the completion of the transaction, the insider now owns 5,626,167 shares in the company, valued at approximately $205,355,095.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold a total of 134,715 shares of company stock valued at $4,996,670 in the last 90 days. 37.54% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NRCIA. Schwab Charles Investment Management Inc. boosted its holdings in shares of National Research by 0.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 30,453 shares of the business services provider’s stock worth $820,000 after purchasing an additional 190 shares during the period. Neuberger Berman Group LLC boosted its holdings in shares of National Research by 0.9% in the 2nd quarter. Neuberger Berman Group LLC now owns 58,637 shares of the business services provider’s stock worth $1,577,000 after purchasing an additional 545 shares during the period. Alliancebernstein L.P. boosted its holdings in shares of National Research by 5.1% in the 2nd quarter. Alliancebernstein L.P. now owns 12,369 shares of the business services provider’s stock worth $333,000 after purchasing an additional 600 shares during the period. Teachers Advisors LLC boosted its holdings in shares of National Research by 36.6% in the 2nd quarter. Teachers Advisors LLC now owns 17,691 shares of the business services provider’s stock worth $476,000 after purchasing an additional 4,736 shares during the period. Finally, Citigroup Inc. boosted its holdings in shares of National Research by 120.2% in the 2nd quarter. Citigroup Inc. now owns 8,299 shares of the business services provider’s stock worth $224,000 after purchasing an additional 4,531 shares during the period. Institutional investors and hedge funds own 24.90% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Zacks: National Research Co. (NRCIA) Given Average Recommendation of “Hold” by Analysts” was originally published by Markets Daily and is the property of of Markets Daily. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.themarketsdaily.com/2018/01/11/zacks-national-research-co-nrcia-given-average-recommendation-of-hold-by-analysts.html.

About National Research

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Get a free copy of the Zacks research report on National Research (NRCIA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply